Advanced search
Publication Cover
Annals of Medicine Volume 51, 2019 - Issue 3-4
Submit an article Journal homepage
2,511
Views
14
CrossRef citations to date
0
Altmetric
Articles

Ten-year experience with transcatheter and surgical aortic valve replacement in Finland

Timo MäkikallioDepartment of Internal Medicine, Oulu University Hospital, Oulu, Finland; Correspondence[email protected]
,
Maina P. JalavaHeart Center, Turku University Hospital and University of Turku, Turku, Finland; ORCID Iconhttp://orcid.org/0000-0002-9956-4978
ORCID Icon,
Annastiina HussoHeart Center, Kuopio University Hospital, Kuopio, Finland;
,
Marko VirtanenHeart Hospital, Tampere University Hospital, Tampere, Finland;
,
Teemu LaaksoHeart Center, Helsinki University Hospital, Helsinki, Finland;
,
Tuomas AhvenvaaraDepartment of Surgery, Oulu University Hospital and University of Oulu, Finland;
,
Tuomas TauriainenDepartment of Surgery, Oulu University Hospital and University of Oulu, Finland;
,
Pasi MaaranenHeart Hospital, Tampere University Hospital, Tampere, Finland;
,
Eeva-Maija KinnunenHeart Center, Helsinki University Hospital, Helsinki, Finland;
,
Sebastian DahlbackaHeart Center, Helsinki University Hospital, Helsinki, Finland;
,
Jussi JaakkolaHeart Center, Turku University Hospital and University of Turku, Turku, Finland;
,
Juhani AiraksinenHeart Center, Turku University Hospital and University of Turku, Turku, Finland; ORCID Iconhttp://orcid.org/0000-0002-0193-568X
ORCID Icon,
Vesa AnttilaHeart Center, Turku University Hospital and University of Turku, Turku, Finland;
,
Mikko SavontausHeart Center, Turku University Hospital and University of Turku, Turku, Finland;
,
Mika LaineHeart Center, Helsinki University Hospital, Helsinki, Finland;
,
Tatu JuvonenHeart Center, Helsinki University Hospital, Helsinki, Finland;
,
Antti ValtolaHeart Center, Kuopio University Hospital, Kuopio, Finland;
,
Peter RaivioHeart Center, Helsinki University Hospital, Helsinki, Finland;
,
Markku EskolaHeart Hospital, Tampere University Hospital, Tampere, Finland;
,
Matti NiemeläDepartment of Internal Medicine, Oulu University Hospital, Oulu, Finland;
&
Fausto BiancariHeart Center, Turku University Hospital and University of Turku, Turku, Finland; ;Department of Surgery, Oulu University Hospital and University of Oulu, Finland; ;Department of Surgery, University of Turku, Turku, FinlandORCID Iconhttp://orcid.org/0000-0001-5028-8186
ORCID Icon show all
Pages 270-279 | Received 13 Jan 2019, Accepted 20 Feb 2019, Published online: 21 May 2019

Figures & data

Figure 1. Study flowchart and annual number of transcatheter (TAVR) and surgical aortic valve replacement (SAVR) along the study period.

Figure 1. Study flowchart and annual number of transcatheter (TAVR) and surgical aortic valve replacement (SAVR) along the study period.

Figure 2. Frequencies of transcatheter (TAVR) and surgical aortic valve replacement (SAVR) along the study period.

Figure 2. Frequencies of transcatheter (TAVR) and surgical aortic valve replacement (SAVR) along the study period.

Table 1. Characteristics of patients who underwent transcatheter or surgical aortic valve replacement.

Figure 3. Operative risk stratified by the Society of Thoracic Surgeons (STS) score in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR) along the study period.

Figure 3. Operative risk stratified by the Society of Thoracic Surgeons (STS) score in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR) along the study period.

Figure 4. Observed and predicted 30-day mortality by the Society of Thoracic Surgeons (STS) score in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR) along the study period. P-values are from the linear-by-linear association test.

Figure 4. Observed and predicted 30-day mortality by the Society of Thoracic Surgeons (STS) score in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR) along the study period. P-values are from the linear-by-linear association test.

Figure 5. Two years survival in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR) from 2018 to 2015. p-Values are from the linear-by-linear association test.

Figure 5. Two years survival in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR) from 2018 to 2015. p-Values are from the linear-by-linear association test.

Table 2. Crude rates of adverse events occurred during the index hospitalization in patients undergoing transcatheter or surgical aortic valve replacement.

Figure 6. Incidence of stroke, moderate-to-severe paravalvular regurgitation, acute kidney injury stage 3 and length of hospital stay after transcatheter (TAVR) and surgical aortic valve replacement (SAVR) along the study period. P-values are from the linear-by-linear association test.

Figure 6. Incidence of stroke, moderate-to-severe paravalvular regurgitation, acute kidney injury stage 3 and length of hospital stay after transcatheter (TAVR) and surgical aortic valve replacement (SAVR) along the study period. P-values are from the linear-by-linear association test.

Figure 7. Rates of red blood cell (RBC) transfusion and of transfusion of >4 units of RBC and/or operation for excessive bleeding in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR). P-values are from the linear-by-linear association test.

Figure 7. Rates of red blood cell (RBC) transfusion and of transfusion of >4 units of RBC and/or operation for excessive bleeding in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR). P-values are from the linear-by-linear association test.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.